Article

AAO initiates EyeSmart program to educate about eye disease

San Francisco-The risk of age-related eye disease is one that Americans do not realize according to a national health survey conducted by the American Academy of Ophthalmology (AAO). The AAO is issuing a new public initiative called EyeSmart to educate Americans about the risks they face.

San Francisco-The risk of age-related eye disease is one that Americans do not realize according to a national health survey conducted by the American Academy of Ophthalmology (AAO). The AAO is issuing a new public initiative called EyeSmart to educate Americans about the risks they face.

Only 11% of Americans find themselves at high risk for eye disease according to a survey conducted by Greenberg Quinlan Rosner Research. Americans over the age of 65 are the most at risk, however, only 10% believe they are at risk.

Age-related eye diseases such as cataract, diabetic retinopathy, glaucoma, and age-related macular degeneration are expected to increase from 28 million to 43 million by the year 2020, according to the organization. Americans are more concerned with weight gain and joint and back pain then they are with vision loss.

The AAO recommends that adults with no signs or risk factors for eye disease get a baseline eye disease screening at age 40. People with a family history of eye disease, diabetes, or high blood pressure should consult their physician to determine how often an examination is needed.

Related Videos
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
© 2025 MJH Life Sciences

All rights reserved.